Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA.
Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, USA.
Biomaterials. 2019 Jan;189:1-10. doi: 10.1016/j.biomaterials.2018.10.024. Epub 2018 Oct 22.
The maintenance and direction of stem cell lineage after implantation remains challenging for clinical translation. Aggregation and encapsulation into instructive biomaterials after preconditioning can bolster retention of differentiated phenotypes. Since these procedures do not depend on cell type or lineage, we hypothesized we could use a common, tunable platform to engineer formulations that retain and enhance multiple lineages from different cell populations. To test this, we varied alginate stiffness and adhesive ligand content, then encapsulated spheroids of varying cellularity. We used Design-of-Experiments to determine the effect of these parameters and their interactions on phenotype retention. The combination of parameters leading to maximal differentiation varied with lineage and cell type, inducing a 2-4-fold increase over non-optimized levels. Phenotype was also retained for 4 weeks in a murine subcutaneous model. This widely applicable approach can facilitate translation of cell-based therapies by instructing phenotype in situ without prolonged induction or costly growth factors.
植入后干细胞谱系的维持和定向仍然是临床转化的挑战。在预处理后聚集和封装到有指导作用的生物材料中可以增强分化表型的保留。由于这些程序不依赖于细胞类型或谱系,我们假设我们可以使用通用的、可调的平台来设计配方,以保留和增强来自不同细胞群的多种谱系。为了验证这一点,我们改变了藻酸盐的刚度和粘附配体的含量,然后封装了不同细胞密度的球体。我们使用实验设计来确定这些参数及其相互作用对表型保留的影响。导致最大分化的参数组合因谱系和细胞类型而异,与非优化水平相比,诱导增加了 2 到 4 倍。表型在小鼠皮下模型中也能保留 4 周。这种广泛适用的方法可以通过在原位指导表型而无需长时间诱导或昂贵的生长因子来促进基于细胞的治疗的转化。